Young women of Gen Z are reportedly more informed about periods, including concepts like PMOS and cycle syncing, and are now educating their mothers on these topics.

ChipMOS reported a record-high July revenue with a 44% year-over-year jump, while ASE Technology also saw its net revenue surge by 43% year-over-year to NT$73.8 billion in July.

Pakistan's Prime Minister has introduced an AI-based system, PMOS, designed to digitize governance and enhance the tracking and implementation of official directives.

ChipMOS Technologies has announced record monthly and quarterly revenue figures, marking its highest performance since 2014. This achievement signals strong financial growth for the semiconductor company.

Actress Bhagyashree has shared a home remedy for PMOS, emphasizing its lack of side effects.

ChipMOS Technologies Inc. announced a significant increase in its May revenue, rising by nearly 18% compared to the same period last year.

Deere & Company declared a quarterly dividend of $1.62 per share, while ChipMOS Technologies announced a cash dividend of $0.78 per share. Both companies made their respective dividend declarations.

Polycystic Ovary Syndrome (PCOS) has been renamed to Polycystic Ovarian Syndrome (PMOS), a change highlighted as an important step. The endocrine disorder affects one in eight women, impacting not only fertility but the entire system.

Polycystic Ovary Syndrome (PCOS) is receiving a new name, prompting discussions on how this change might lead to better treatment and care for patients.

Polycystic Ovary Syndrome (PCOS) is being renamed to Polycystic Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex and broader health effects on women.

Women's health experts have proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a landmark paper, hoping the new name will improve diagnosis and treatment for the condition affecting one in eight women globally.

Women's health experts have proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a landmark paper published in The Lancet medical journal, warning that the current name could be misleading patients.

ChipMOS announced a significant 32.2% year-over-year increase in its revenue for April.

ChipMOS reported GAAP EPADS of $0.46 and revenue of $207.9 million, missing analyst estimates by $0.93 million.

New research indicates that obesity drugs are showing early promise in treating the hormonal disorder PMOS, offering hope to affected families.

The article discusses Polycystic Ovary Syndrome (PCOS) and Polycystic Menstrual Ovary Syndrome (PMOS), a condition affecting one in eight women, emphasizing the need for lifelong lifestyle changes and addressing common misconceptions.

An article discusses the silent metabolic crisis that is contributing to the emergence of new disease names, ranging from PMOS to CKM.

New research suggests a link between prenatal exposure to 'forever chemicals' (PFAS) and the later development of polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS.

Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its understanding as a hormonal and metabolic disorder, as many women with the condition do not have ovarian cysts.

The risk posed by Israeli intelligence over the years was rated as high. In recent weeks, it was increased to 'critical', the topmost level.

Polycystic Ovary Syndrome (PCOS) has officially changed its name to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in mid-May 2026. This change, published in The Lancet, follows years of research and appeals from international health organizations, aiming for faster diagnosis.

The renaming of PCOS to PMOS is discussed for its potential to change how Indian women approach diabetes prevention.

An article clarifies the differences between PMOS (Post-Menstrual Syndrome) and PCOS (Polycystic Ovary Syndrome), providing insights into women's health conditions.

An AIIMS doctor explains the significance of the renaming of Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Ovary Syndrome (PMOS), marking a landmark shift in medical understanding.

Polycystic Ovary Syndrome (PCOS) has been officially renamed Polycystic Metabolic Ovarian Syndrome (PMOS) after a 14-year global effort, aiming to better reflect the condition's hormonal and metabolic nature and improve diagnoses.

Actress Kangana Ranaut has commented on Deepika Padukone's demand for an 8-hour work shift, while a psychiatrist discusses ways to build healthier schedules in the entertainment industry.

Katsina State Governor Dikko Radda informed international partners that Katsina State is recognized as one of Nigeria's most business-friendly states, aiming to attract further investment.

Dita e Verës është kthyer në një traditë të përvitshme feste për të gjithë grupmoshat.

Several companies, including SeaStar Medical, Leslie's, and Liftoff Mobile, have released their Q2 2026 earnings, with mixed results regarding EPS and revenue targets. Additionally, previews for Q2 2026 earnings were provided for Global Water Resources, MediWound, and Tecogen.

PMOS, a hormonal disorder formerly known as PCOS, affects approximately one in eight women but remains largely unknown. A new name and guidelines for patients are expected to improve care for this condition.

The medical community has announced that Polycystic Ovary Syndrome (PCOS) will be officially renamed to Polyendocrine Metabolic Ovary Syndrome (PMOS) starting May 12, 2026, following a decision at the European Congress of Endocrinology.

A health watchdog has reiterated its recommendation for women diagnosed with PMOS (Premature Menopause or Ovarian Syndrome) to receive yearly checks from the NHS, emphasizing that the condition remains under-diagnosed and inconsistently managed despite affecting millions in the UK.

A discussion on the evolving understanding of Polycystic Ovary Syndrome (PCOS), suggesting it should be primarily understood as a metabolic health issue rather than solely a reproductive one.

A discussion highlights the renaming of PCOS to PMOS and questions why there is still a significant lack of knowledge surrounding the condition.

The medical condition Polycystic Ovary Syndrome (PCOS) has been renamed to Polycystic Metabolic Ovary Syndrome (PMOS), but women express skepticism that a name change alone will address their struggles.

Women are reacting to the proposed change of the medical term PCOS (Polycystic Ovary Syndrome) to PMOS, viewing it as a 'small win'.

An article explores the reasons why renaming Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Ovarian Syndrome (PMOS) is considered more significant than commonly perceived, highlighting the implications of such a change.

Polycystic Ovary Syndrome (PCOS) is potentially being renamed to PMOS, and this article discusses what the new name could mean for the women affected by the condition.

Polycystic Ovary Syndrome (PCOS) has been renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to more accurately reflect its broad health impacts, with doctors hoping the change will improve patient care globally.

Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) after more than a decade of discussion. This change is hoped to lead to earlier diagnosis and a more holistic approach to treatment for millions of affected women.

Polycystic ovary syndrome is being relabelled polyendocrine metabolic ovarian syndrome to correct the misconception that it is solely a gynaecological disease that creates ovarian cysts. Here’s what you need to know about the condition • ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women • ‘I still want to scream’: the loneliness and confusion of living with PMOS With polycystic ovary syndrome (PCOS) now being rebadged as polyendocrin...

ChipMOS, a semiconductor company, announced a significant 25.4% year-over-year jump in its first-quarter revenue. March sales also surged by 23.1%, indicating robust performance.

Stating that the safety of the operations is the topmost priority during this crisis, the Minister said there is no reason for us to operate in this area when the airspace itself is closed

ASE Technology reported a month-over-month dip in net revenue for February, though the company still saw year-over-year growth in its financial performance.